about
Biomarkers and recent advances in the management and therapy of sickle cell diseaseSickle Cells Abolish Melanoma Tumorigenesis in Hemoglobin SS Knockin Mice and Augment the Tumoricidal Effect of Oncolytic Virus In VivoAcid sphingomyelinase is activated in sickle cell erythrocytes and contributes to inflammatory microparticle generation in SCD.Microvascular oxygen consumption during sickle cell pain crisis.Pattern of serum cytokine expression and T-cell subsets in sickle cell disease patients in vaso-occlusive crisis.TNF-α, IFN-γ, IL-10, and IL-4 levels were elevated in a murine model of human sickle cell anemia maintained on a high protein/calorie diet.Participation of Mac-1, LFA-1 and VLA-4 integrins in the in vitro adhesion of sickle cell disease neutrophils to endothelial layers, and reversal of adhesion by simvastatinIron, inflammation, and early death in adults with sickle cell disease.Interethnic diversity of the CD209 (rs4804803) gene promoter polymorphism in African but not American sickle cell diseaseThe sickle cell mouse lung: proinflammatory and primed for allergic inflammation.Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management.Immune parameter analysis of children with sickle cell disease on hydroxycarbamide or chronic transfusion therapySplenic morphological changes are accompanied by altered baseline immunity in a mouse model of sickle-cell diseaseHaptoglobin gene polymorphisms and interleukin-6 and -8 levels in patients with sickle cell anemia.A pilot study of the short-term use of simvastatin in sickle cell disease: effects on markers of vascular dysfunction.Sickle cell vaso-occlusion causes activation of iNKT cells that is decreased by the adenosine A2A receptor agonist regadenosonHistopathology of experimentally induced asthma in a murine model of sickle cell disease.Cysteine-iron promotes arginase activity by driving the Fenton reaction.Quantitative sensory testing and pain-evoked cytokine reactivity: comparison of patients with sickle cell disease to healthy matched controls.C-reactive protein and interleukin-6 are decreased in transgenic sickle cell mice fed a high protein diet.Alloimmunization is associated with older age of transfused red blood cells in sickle cell diseasePain frequency, severity and QT dispersion in adult patients with sickle cell anemia: correlation with inflammatory markers.Interplay between coagulation and vascular inflammation in sickle cell disease.Organ damage in sickle cell disease study (ORDISS): protocol for a longitudinal cohort study based in Ghana.Red cell DAMPs and inflammation.Comment on "Influence of βS-globin haplotypes and hydroxyurea on tumor necrosis factor-alpha levels in sickle cell anemia".Substance P is increased in patients with sickle cell disease and associated with haemolysis and hydroxycarbamide use.Prevalence and Clinical Characteristics of Rheumatoid Arthritis in an Inner City Population with Sickle Cell Disease.Clinical significance of assessment of thrombospondin and placenta growth factor levels in patients with sickle cell anemia: two centers egyptian studies.In vitro evidence of the inhibitory capacity of chloroquine on arginase activity in sickle erythrocytes.Rheumatoid Arthritis in Sickle-Cell Population: Pathophysiologic Insights, Clinical Evaluation and Management.Developing new pharmacotherapeutic approaches to treating sickle-cell disease.Red blood cell alloimmunization is influenced by recipient inflammatory state at time of transfusion in patients with sickle cell disease.Adult Sickle Cell Anaemia Patients in Bone Pain Crisis have Elevated Pro-Inflammatory Cytokines.Vitamin D Deficiency and Its Association with Inflammatory Markers, Lipid Profile and Regulatory T-cells in Pediatric Sickle Cell Disease Patients
P2860
Q28082462-DAB162B4-F313-470C-910A-A658551B9D22Q28596621-EB3A29CE-F237-43AE-BBEE-996AF245CD0CQ30370837-B3625DCC-4FF7-4A6D-AB85-0805BF1EF608Q33621596-735D8EAC-F1BB-489C-B317-3E50ADF791D1Q33768693-92F0981F-5098-4BDA-BB51-9B9D014508C1Q34180765-3C9B854D-2F34-4F76-942B-508C9814904FQ34750520-3488152A-ECBA-4497-8DE3-30E2CE0ECF87Q34979516-C92F9B6C-8151-48D2-BDBD-D64BBA7A79C6Q35145919-C1C7C0DE-EEFF-42F1-BCF7-56CBF9F90336Q35958161-5E9EF197-5E76-43F4-BED0-27B8EFFB48DCQ36106307-70E7459F-FD59-4266-AAAF-248016E27777Q36343931-A73246A5-3D50-4185-9932-046B62F472A4Q36355641-921AA9EB-5D00-43E0-AE1E-6ABFE74DCE1BQ36387512-0DF5211D-5BFB-491E-A664-6D42DE127494Q36697677-96BB9A6A-4AA8-4D3A-AECF-7084763BB30CQ36797240-25208230-359A-4637-8215-5E5ECC43677AQ36868781-33B5DEA9-6D23-44B6-B22C-A8F41D4C0473Q36979880-722783CD-4E60-4B34-8A9B-2A0E13BEF0D0Q37064951-887640F1-AD7D-4E71-88B0-74F9ACBDA777Q37128824-87E3AA12-5168-4278-9666-2C90D9C01AD0Q37254929-941599FC-D552-4EFD-A667-6CD9789785FCQ37398404-DFDCD104-0309-4DBF-8E85-A85321F839C2Q38099667-0CDC65C2-220B-47F0-9333-BE2FFC3C4305Q38603158-C368519E-EA1B-4EC5-B5E8-83B4B749EC9CQ38850672-0BE1A79B-29A8-487C-B53D-F2B56EEDFB84Q39090372-B9F4375E-4209-4313-9CC6-4E7896513018Q41635275-2E333CAA-98FA-4F08-88E8-7435D8272B11Q41703473-492438A8-C9D5-4F22-AE0A-2B6CFD55C15DQ41905955-0A0EDCB9-4F6B-414B-A71C-5F12DC1430A7Q41942150-72E9DB2A-3C35-4235-BFDE-4E887E90E21FQ49520307-416E12C1-B9A6-43C6-A56B-02C45E242830Q50207951-483DDCDD-857A-465D-84AF-678531AC5038Q50459485-F87E1E74-7F0D-43DE-A8D0-D2E186177EFBQ55013382-5DE58F5A-61EA-4F48-ACC0-86460A78FC06Q56529775-07B55473-0837-4DD6-91DD-B557B22A6D3A
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Cytokine profile of sickle cell disease in Oman.
@en
Cytokine profile of sickle cell disease in Oman.
@nl
type
label
Cytokine profile of sickle cell disease in Oman.
@en
Cytokine profile of sickle cell disease in Oman.
@nl
prefLabel
Cytokine profile of sickle cell disease in Oman.
@en
Cytokine profile of sickle cell disease in Oman.
@nl
P2093
P356
P1476
Cytokine profile of sickle cell disease in Oman
@en
P2093
Adel Alwan Alnaqdy
David Dennison
Huxley Knox-Macaulay
Salam Al Kindi
Shahina Daar
P304
P356
10.1002/AJH.20196
P577
2004-12-01T00:00:00Z